Tectonic Therapeutic, Inc.
TECX
$16.68
-$0.16-0.95%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 4.84M | 5.32M | 4.35M | 2.15M | 2.18M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 13.99M | 19.64M | 11.42M | 12.97M | 9.37M |
Operating Income | -13.99M | -19.64M | -11.42M | -12.97M | -9.37M |
Income Before Tax | -12.37M | -17.72M | -12.67M | -15.22M | -7.87M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -12.37M | -17.72M | -12.67M | -15.22M | -7.87M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -12.37M | -17.72M | -12.67M | -15.22M | -7.87M |
EBIT | -13.99M | -19.64M | -11.42M | -12.97M | -9.37M |
EBITDA | -13.48M | -19.21M | -11.09M | -12.59M | -9.00M |
EPS Basic | -0.84 | -1.20 | -4.34 | -5.83 | -5.89 |
Normalized Basic EPS | -0.52 | -0.75 | -2.71 | -3.65 | -3.68 |
EPS Diluted | -0.84 | -1.20 | -4.34 | -5.83 | -5.89 |
Normalized Diluted EPS | -0.52 | -0.75 | -2.71 | -3.65 | -3.68 |
Average Basic Shares Outstanding | 14.79M | 14.73M | 2.92M | 2.61M | 1.34M |
Average Diluted Shares Outstanding | 14.79M | 14.73M | 2.92M | 2.61M | 1.34M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |